The Worldwide Market for In Vitro Diagnostics, 13th Edition
Description
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2025 for defined segments of the IVD market and various sub-segments, including:
- COVID Testing – Immunoassays and Molecular
- Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal)
- Clinical Chemistry and “Core Lab” Markets
- Point-of-Care Testing (POC) (Professional and Self-Testing)
- Glucose Testing
- Substance Abuse Testing
- Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
- Blood Banking
- Pap, ISH, IHC, HPV and Other Tissue-Based Tests
- Infectious Disease Immunoassay Testing
- Hematology
- Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
- Coagulation Tests
- Quality Control
For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2025 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers’ product innovations. The market data is put into a context with real-world industry and medical practice trends.
The Worldwide Market for In Vitro Diagnostic Tests has been called “The Bible of the IVD Industry” by customers, which include top IVD firms. Using Kalorama Information’s The Worldwide Market for In vitro Diagnostic (IVD) Tests, 13th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.
Country-Level Coverage
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
US
Germany
UK
France
Spain
Italy
Russia
Netherlands
Turkey
Poland
Canada
China
Japan
Malaysia
Singapore
South Korea
Australia
Saudi Arabia
Brazil
Argentina
Colombia
Chile
Peru
South Africa
Eastern Europe
Emerging Markets
Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2020.
Competitive Analysis and Corporate Profiling
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies. First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report. Companies profiled include:
A. Menarini Diagnostics
Abbott Diagnostics
Arkray
Becton, Dickinson (BD)
Beckman Coulter
bioMerieux
Bio-Rad
Bruker
Cepheid
Danaher
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Hologic
Illumina
Instrumentation Laboratory
Lab Corp.
Leica Biosystems
Nova Biomedical
Meridian Bioscience, Inc.
Mindray
Perkin Elmer
Qiagen
Quest
Quidel
Radiometer
Randox
Roche Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher Scientific
Werfen
*Note: The Online Download pricing option allows for 1-10 users in a single department, at a single location*
Table of Contents
1200 Pages
- The Worldwide IVD Market, 2019, 2020 and 2025 ($billions)
- Scope and Methodology
- Size and Growth of the Market
- IVD Market Highlights
- Competitive Picture in IVD
- What to Watch Long-Term
- Finding What You Are Looking For in the 13th Edition
- Report Design and Changes in Segments
- IVD Landscape
- The Challenge of PAMA
- Market Analysis of IVD Market Segments
- Top Suppliers and Niche Players
- The Impact of COVID for the Top Tier Companies
- IVD Companies Mergers & Acquisitions
- Distribution Agreements
- Licenses and Collaboration Agreements
- Test Services
- Historical IVD Market vs Today
- Point of View
- COVID-19 Impact and Summary
- Background
- Global Population and Aging
- Shifting Disease Burdens
- COVID-19
- Emerging and Emerged Markets
- Size and Forecast for the Global IVD Market
- The IVD Market in the United States
- IVD Market in Europe: Growing Markets
- Eastern Europe: Growth Region
- Japan: Return to Growth
- China: Current IVD Market
- India: Population and Opportunity
- Rest of Asia
- Brazil
- Mexico
- The Russian Federation
- Canada
- Emerging Markets
- IVD Market Opportunity by Country
- Introduction
- Gene Editing
- Microbiome
- Liquid Biopsy
- IVD Information Technology and AI
- Substance Abuse: IVD Implications
- Clinical Laboratory Kickback Schemes
- Sepsis: A 17 Billion-Dollar Problem
- Overview and Trends
- Professional POC
- OTC Self Testing
- Pregnancy/Fertility Tests
- Colon Cancer Screening
- Lipid Testing
- POC Infectious Disease Testing
- Diabetes Testing – Blood Glucose Monitoring
- The Major POC Test Players
- Core Lab Overview and Trends
- Connectivity
- Overview of Chemistry Tests
- Market Analysis
- Sleep Apnea Testing: Core Lab Solution?
- The Commercial Outlook for Chemistry Tests
- Overview and Trends
- Market Analysis
- Mature Assay Segment
- Maturing Immunoassays
- Growth Immunoassays
- Innovating POC
- The Commercial Outlook for Immunoassays
- Overview
- Sample Preparation and Quality Control
- Advanced Molecular Tests and Technologies
- Major Players
- Market Analysis
- The Commercial Outlook for Molecular Tests
- Overview of Hematology and Trends
- Laboratory-based Hematology Testing
- Decentralized Hematology Testing
- Market Analysis: Leading Suppliers
- The Commercial Outlook for Hematology Tests
- Overview and Trends of Coagulation and Immunohematology Tests
- Special Topics
- Market Analysis
- Lab-based Testing
- Leading Suppliers: Laboratory Systems
- Decentralized Coagulation Testing – Professional Use
- Leading Suppliers: POC Systems
- The Commercial Market for Coagulation Tests
- The Real Impact of Infections
- Microbial Antibiotic Resistance – The Role of Clinical Tests
- Traditional Microbiology and Its Limits
- The New Microbiology - Innovations
- New Infectious Disease Threats
- Microbiology Firms Acquisitions and Collaborations
- Market Analysis
- Market Analysis - Traditional Microbiology ID/AST
- Market Analysis - Microbiology Immunoassays
- Market Analysis - Molecular Microbiology
- Mass Spectrometry
- The Future Outlook for Microbiology
- Overview
- Global Blood Safety
- Blood Typing and Grouping Market
- Blood Testing Market
- The Commercial Outlook for Blood Banking Testing
- Overview
- Special Topics
- Market Analysis
- The Commercial Outlook for Histology and Cytology Tests
- Abbott Diagnostics
- Agilent Technologies
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Cepheid / Danaher
- Danaher Corporation
- DiaSorin S.p.A
- Grifols S.A.
- Hologic, Inc.
- Instrumentation Laboratory (IL) / Werfen
- Leica Biosystems/Danaher
- Ortho Clinical Diagnostics (Ortho)
- PerkinElmer, Inc. (PE)
- QIAGEN
- Quidel Corporation
- Radiometer A/S / Danaher
- Roche Diagnostics
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Ventana Medical Systems Inc. / Roche Tissue Diagnostics
- Werfen
- ARKRAY
- BGI Genomics (formerly Beijing Genome Institute)
- Dexcom
- Diagnostica Stago S.A.S.
- Eiken Chemical Co., Ltd
- Exact Sciences
- Fujirebio Diagnostics, Inc.
- GenMark Diagnostics
- Guardant Health
- Horiba
- Illumina
- LabCorp, Laboratory Corporation of America
- Luminex Corporation
- Masimo Corporation
- A. Menarini Diagnostics
- Meridian Bioscience, Inc.
- Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Myriad Genetics, Inc.
- Nihon Kohden Corporation
- Nova Biomedical Corporation (Nova)
- Philips (Royal Philips)
- Quest Diagnostics
- Randox Laboratories Ltd.
- Bloodsource (Vitalant)
- Cerus Corporation
- Haemokinesis Pty Ltd
- Immucor
- MicroTyping Concepts
- Quotient Limited
- Reliance Life Sciences
- AB SCIEX Pte Ltd.
- EKF Diagnostics Holdings Plc
- ELITech Group S.A.S.
- ERBA Diagnostics, Inc.
- MedTest DX
- Microsaic Systems plc
- Nova Biomedical
- Scienion AG
- Sekisui Diagnostics LLC
- Shimadzu Scientific Instruments
- Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
- Tecan Group
- Tosoh Bioscience
- Trinity Biotech Plc
- Angle, plc
- Biocartis
- Biocept, Inc.
- Biodesix
- Epic Sciences
- Epigenomics AG
- Foundation Medicine, Inc.
- Genomic Health (Exact Sciences)
- Guardant Health, Inc.
- LungLife AI
- Menarini-Silicon Biosystems
- Myriad Genetics, Inc.
- Natera
- NeoGenomics
- Ascensia Diabetes Care Holdings AG
- Bigfoot Biomedical Inc.
- Debiotech SA
- Dexcom Inc.
- Gentag Inc.
- Glooko Inc.
- GlySure Limited
- Glytec LLC
- iHealth Labs Inc.
- Insulet Corporation
- Integrity Applications Inc.
- LifeScan Inc.
- Medtronic plc
- Nemaura Medical Inc.
- Nightscout Project
- Trividia Health Inc.
- Verily Life Sciences LLC
- CellaVision AB
- Diagnostica Stago, S.A.S.
- DIAGON Kft. Hungary
- Horiba Medical
- Medica Corporation
- Microvisk Technologies
- West Medica
- Advanced Cell Diagnostics (ACD)
- Amoy Diagnostics Co. Ltd.
- Applied Spectral Imaging Inc. (ASI)
- BioGenex Laboratories, Inc.
- BioView Ltd.
- Circulomics Inc.
- Dako A/S
- HTG Molecular Diagnostics
- Leica Biosystems
- MilliporeSigma (formerly EMD Millipore)
- Visiopharm
- BG Medicine, Inc
- Binding Site Group Ltd. (The)
- Biodesix
- Biohit Healthcare
- Biomerica Inc.
- Bio-Techne Corporation
- Corgenix Medical Corporation
- Critical Diagnostics
- Eurobio Scientific
- EUROIMMUN AG
- HOB Biotech
- Immunodiagnostic Systems (IDS)
- INOVA Diagnostics, Inc.
- One Lambda, Inc
- Orgentec Diagnostika
- Protagen Diagnostics
- Response Biomedical Corp.
- Theradig
- VolitionRx Limited
- Advaita Corp.
- Cerner Corp.
- Dell Technologies Inc.
- Desktop Genetics Ltd.
- DNAnexus Inc.
- Edico Genome (Illumina)
- Euformatics Oy
- GenomOncology LLC
- Google LLC
- Human Longevity Inc.
- Intel Corporation
- International Business Machines Corp. (IBM)
- N-of-One
- PierianDx
- Rennova Health, Inc.
- SOPHiA GENETICS SA
- Sunquest Information Systems Inc.
- WuXi NextCODE
- Accelerate Diagnostics, Inc.
- Advanced Biological Laboratories, S.A. (ABL)
- altona Diagnostics
- ArcDia International Oy Ltd.
- BioFire Diagnostics, LLC. (Acquired by bioMérieux)
- Bruker BioSciences Corporation
- COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
- Curetis
- Fast Track Diagnostics (Acquired by Siemens Healthineers)
- Focus Diagnostics, Inc.
- Genetic Analysis AS
- GeneWEAVE Biosciences, Inc.
- Greiner Bio-One International GmbH
- Hain Lifescience GmbH
- Mast Group
- Mobidiag
- Q-linea AB
- OpGen, Inc.
- Seegene, Inc.
- Specific Technologies
- Synbiosis Ltd.
- T2 Biosystems
- Asuragen Inc.
- AutoGenomics Inc.
- Enzo Biochem Inc.
- Exosome Diagnostics, Inc.
- Fluidigm Corporation
- GenMark Diagnostics, Inc
- Genome Diagnostics BV (GenDx)
- NanoString Technologies, Inc.
- Oxford Nanopore Technologies Ltd
- Pacific Biosciences of California, Inc. (PacBio)
- QuanDx Inc
- Takara Bio Inc.
- Vela Diagnostics
- Abaxis, Inc.
- Abingdon Health Ltd.
- Binx Health
- Biomeme, Inc.
- Chembio Diagnostic Systems, Inc.
- DNA Electronics Ltd (DNAe)
- Entopsis
- Fio Corporation
- Genedrive plc (formerly Epistem Holdings)
- NuGenerex Diagnostics (HDS)
- Immunostics, Inc.
- InSilixa Inc.
- Loop Medical
- MedMira, Inc.
- OraSure Technologies, Inc.
- PTS Diagnostics
- QuantuMDx Group, Ltd.
- Rheonix, Inc.
- Samsung Healthcare
- Veredus Laboratories Pte Ltd
- Affymetrix, Inc.
- Berry Genomics Co. ltd.
- CooperGenomics (Division of CooperSurgical)
- Eurofins LifeCodexx AG
- Myriad Women's Health
- Genoma Group
- Innovations Exchange Pte Ltd (INEX) and iGene Diagnostics Pte Ltd
- Invitae
- Oxford Gene Technology
- Ravgen
- Reproductive Genetics Innovations
- Sequenom, Inc.
- Yourgene Health
- 10x Genomics
- Agena Bioscience, Inc.
- Biotype Diagnostic GmbH
- DxTerity Diagnostics Inc.
- Horizon Discovery Group plc
- IncellDx
- LGC SeraCare Life Sciences, Inc.
- Oasis Diagnostics Corporation
- PreAnalytiX GmbH
- Precipio, Inc. (formerly Transgenomic)
- Quanterix Corporation
- Streck Inc.
- 23andMe
- Agendia BV
- Ambry Genetics
- ARUP Laboratories
- The BioCollective
- BioReference Laboratories
- Biotheranostics
- BluePrint Genetics Oy
- Boston Heart Diagnostics
- CareDx, Inc.
- Cleveland HeartLab Inc.
- Eurofins Genomics
- Exact Sciences Corp.
- Genomic Vision
- Helomics Corporation
- Mayo Medical Laboratories
- MDxHealth SA
- OPKO Diagnostics
- Pathway Genomics Corporation
- Sonic Healthcare
- Veracyte, Inc.
- Vermillion Inc.
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
